United Capital Financial Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-267,875
| Closed | -$8.3M | – | 1295 |
|
|
2016
Q2 | $8.3M | Buy |
267,875
+6,388
| +2% | +$198K | 0.08% | 280 |
|
|
2016
Q1 | $9.79M | Buy |
261,487
+1,005
| +0.4% | +$37.6K | 0.11% | 207 |
|
|
2015
Q4 | $11.2M | Buy |
260,482
+528
| +0.2% | +$22.8K | 0.13% | 179 |
|
|
2015
Q3 | $9.74M | Buy |
259,954
+2,305
| +0.9% | +$86.4K | 0.12% | 195 |
|
|
2015
Q2 | $8.76M | Buy |
257,649
+7,933
| +3% | +$270K | 0.1% | 237 |
|
|
2015
Q1 | $8.25M | Sell |
249,716
-138,065
| -36% | -$4.56M | 0.1% | 253 |
|
|
2014
Q4 | $13.2M | Sell |
387,781
-45
| -0% | -$1.53K | 0.2% | 131 |
|
|
2014
Q3 | $15M | Buy |
387,826
+918
| +0.2% | +$35.4K | 0.26% | 99 |
|
|
2014
Q2 | $15.1M | Buy |
386,908
+2,495
| +0.6% | +$97.1K | 0.28% | 95 |
|
|
2014
Q1 | $13.1M | Buy |
384,413
+9,380
| +3% | +$321K | 0.28% | 84 |
|
|
2013
Q4 | $7.87M | Buy |
375,033
+318,035
| +558% | +$6.67M | 0.27% | 105 |
|
|
2013
Q3 | $1.34M | Sell |
56,998
-174,729
| -75% | -$4.1M | 0.04% | 305 |
|
|
2013
Q2 | $6.23M | Buy |
+231,727
| New | +$6.23M | 0.17% | 157 |
|